TOKYO -- Fujifilm Holdings will acquire a Danish biopharmaceutical production unit of U.S. company Biogen for an estimated $890 million, the Japanese company's latest effort to strengthen health care operations and ease its reliance on office equipment.
Business deals
Fujifilm to buy Biogen production site for $890m
Deal makes Japanese company world's No. 2 biopharma contract manufacturer
Massachusetts-based Biogen will unload a manufacturing facility in Denmark.
Read Next
Latest on Business deals
